Literature DB >> 29097426

Emerging role of angiogenesis in adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.

Andrea L Frump1, Sébastien Bonnet2, Vinicio A de Jesus Perez3,4, Tim Lahm1,5,6.   

Abstract

Right ventricular (RV) function is the primary prognostic factor for both morbidity and mortality in pulmonary hypertension (PH). RV hypertrophy is initially an adaptive physiological response to increased overload; however, with persistent and/or progressive afterload increase, this response frequently transitions to more pathological maladaptive remodeling. The mechanisms and disease processes underlying this transition are mostly unknown. Angiogenesis has recently emerged as a major modifier of RV adaptation in the setting of pressure overload. A novel paradigm has emerged that suggests that angiogenesis and angiogenic signaling are required for RV adaptation to afterload increases and that impaired and/or insufficient angiogenesis is a major driver of RV decompensation. Here, we summarize our current understanding of the concepts of maladaptive and adaptive RV remodeling, discuss the current literature on angiogenesis in the adapted and failing RV, and identify potential therapeutic approaches targeting angiogenesis in RV failure.

Entities:  

Mesh:

Year:  2017        PMID: 29097426      PMCID: PMC5900357          DOI: 10.1152/ajplung.00374.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  187 in total

1.  Three-dimensional reconstruction of the human capillary network and the intramyocardial micronecrosis.

Authors:  Noboru Kaneko; Ryuko Matsuda; Masashi Toda; Ken Shimamoto
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-10       Impact factor: 4.733

Review 2.  Control of cardiovascular differentiation by microRNAs.

Authors:  Kisho Ohtani; Stefanie Dimmeler
Journal:  Basic Res Cardiol       Date:  2010-12-24       Impact factor: 17.165

Review 3.  A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Authors:  Jose Gomez-Arroyo; Sheinei J Saleem; Shiro Mizuno; Aamer A Syed; Harm J Bogaard; Antonio Abbate; Laimute Taraseviciene-Stewart; Yon Sung; Donatas Kraskauskas; Daniela Farkas; Daniel H Conrad; Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

Review 4.  The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension.

Authors:  Anton Vonk Noordegraaf; Berend E Westerhof; Nico Westerhof
Journal:  J Am Coll Cardiol       Date:  2017-01-17       Impact factor: 24.094

5.  Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse.

Authors:  Masakuni Kido; Lingling Du; Christopher C Sullivan; Xiaodong Li; Reena Deutsch; Stuart W Jamieson; Patricia A Thistlethwaite
Journal:  J Am Coll Cardiol       Date:  2005-11-09       Impact factor: 24.094

6.  Right ventricular oxygen supply parameters are decreased in human and experimental pulmonary hypertension.

Authors:  Gerrina Ruiter; Yeun Ying Wong; Frances S de Man; M Louis Handoko; Richard T Jaspers; Pieter E Postmus; Nico Westerhof; Hans W M Niessen; Willem J van der Laarse; Anton Vonk-Noordegraaf
Journal:  J Heart Lung Transplant       Date:  2012-11-09       Impact factor: 10.247

7.  Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Authors:  Bradley A Maron; Edward Hess; Thomas M Maddox; Alexander R Opotowsky; Ryan J Tedford; Tim Lahm; Karen E Joynt; Daniel J Kass; Thomas Stephens; Maggie A Stanislawski; Erik R Swenson; Ronald H Goldstein; Jane A Leopold; Roham T Zamanian; Jean M Elwing; Mary E Plomondon; Gary K Grunwald; Anna E Barón; John S Rumsfeld; Gaurav Choudhary
Journal:  Circulation       Date:  2016-02-12       Impact factor: 29.690

8.  Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension.

Authors:  Bart G Boerrigter; Harm J Bogaard; Pia Trip; Herman Groepenhoff; Heleen Rietema; Sebastiaan Holverda; Anco Boonstra; Pieter E Postmus; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

9.  Apelin: a new plasma marker of cardiopulmonary disease.

Authors:  Jens Peter Goetze; Jens F Rehfeld; Jørn Carlsen; Regitze Videbaek; Claus B Andersen; Soeren Boesgaard; Lennart Friis-Hansen
Journal:  Regul Pept       Date:  2005-11-02

10.  Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension.

Authors:  C Partovian; S Adnot; S Eddahibi; E Teiger; M Levame; P Dreyfus; B Raffestin; C Frelin
Journal:  Am J Physiol       Date:  1998-12
View more
  18 in total

Review 1.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

2.  Taking it to heart: dissecting cardiopulmonary interactions in diseases of the lung and the cardiovascular system.

Authors:  Tim Lahm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-12       Impact factor: 5.464

Review 3.  Emerging therapies for right ventricular dysfunction and failure.

Authors:  Anna Klinke; Torben Schubert; Marion Müller; Ekaterina Legchenko; Jason G E Zelt; Tsukasa Shimauchi; L Christian Napp; Alexander M K Rothman; Sébastien Bonnet; Duncan J Stewart; Georg Hansmann; Volker Rudolph
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

4.  Inhalation of particulate matter containing free radicals leads to decreased vascular responsiveness associated with an altered pulmonary function.

Authors:  Ashlyn C Harmon; Alexandra Noël; Balamurugan Subramanian; Zakia Perveen; Merilyn H Jennings; Yi-Fan Chen; Arthur L Penn; Kelsey Legendre; Daniel B Paulsen; Kurt J Varner; Tammy R Dugas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-08-20       Impact factor: 5.125

5.  Supra-coronary aortic banding improves right ventricular function in experimental pulmonary arterial hypertension in rats by increasing systolic right coronary artery perfusion.

Authors:  Lian Tian; Ping Yu Xiong; Elahe Alizadeh; Patricia D A Lima; François Potus; Jeffrey Mewburn; Ashley Martin; Kuang-Hueih Chen; Stephen L Archer
Journal:  Acta Physiol (Oxf)       Date:  2020-05-17       Impact factor: 6.311

6.  Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Authors:  Tim Lahm; Ivor S Douglas; Stephen L Archer; Harm J Bogaard; Naomi C Chesler; Francois Haddad; Anna R Hemnes; Steven M Kawut; Jeffrey A Kline; Todd M Kolb; Stephen C Mathai; Olaf Mercier; Evangelos D Michelakis; Robert Naeije; Rubin M Tuder; Corey E Ventetuolo; Antoine Vieillard-Baron; Norbert F Voelkel; Anton Vonk-Noordegraaf; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

7.  Improving Right Ventricular Function by Increasing BMP Signaling with FK506.

Authors:  Mario Boehm; Xuefei Tian; Md Khadem Ali; Yuqiang Mao; Kenzo Ichimura; Mingming Zhao; Kazuya Kuramoto; Svenja Dannewitz Prosseda; Giovanni Fajardo; Melanie J Dufva; Xulei Qin; Vitaly O Kheyfets; Daniel Bernstein; Sushma Reddy; Ross J Metzger; Roham T Zamanian; Francois Haddad; Edda Spiekerkoetter
Journal:  Am J Respir Cell Mol Biol       Date:  2021-09       Impact factor: 6.914

8.  Vascular Adaptation of the Right Ventricle in Experimental Pulmonary Hypertension.

Authors:  Brian B Graham; Rahul Kumar; Claudia Mickael; Biruk Kassa; Dan Koyanagi; Linda Sanders; Li Zhang; Mario Perez; Daniel Hernandez-Saavedra; Carolyn Valencia; Kandice Dixon; Julie Harral; Zoe Loomis; David Irwin; Travis Nemkov; Angelo D'Alessandro; Kurt R Stenmark; Rubin M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  2018-10       Impact factor: 7.748

9.  Cardiac remodelling in a swine model of chronic thromboembolic pulmonary hypertension: comparison of right vs. left ventricle.

Authors:  Kelly Stam; Zongye Cai; Nikki van der Velde; Richard van Duin; Esther Lam; Jolanda van der Velden; Alexander Hirsch; Dirk J Duncker; Daphne Merkus
Journal:  J Physiol       Date:  2019-07-25       Impact factor: 5.182

Review 10.  Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.

Authors:  Sasha Z Prisco; Thenappan Thenappan; Kurt W Prins
Journal:  JACC Basic Transl Sci       Date:  2020-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.